Simplex Trading, LLC Macrogenics Inc Transaction History

Simplex Trading, LLC

$2.98 Billion
Q2 2024

A detailed history of Simplex Trading, LLC transactions in Macrogenics Inc stock. As of the latest transaction made, Simplex Trading, LLC holds 28,657 shares of MGNX stock, worth $91,415. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,657

Previous 11,720 144.51%

Holding current value

$91,415

Previous $172,000 29.65%

% of portfolio

0.0%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$3.31 - $18.51 $56,061 - $313,503	16,937 Added 144.51%	28,657 $121,000
Q1 2024 Apr 25, 2024	BUY	$9.77 - $21.47 $105,555 - $231,961	10,804 Added 1179.48%	11,720 $172,000
Q4 2023 Feb 02, 2024	SELL	$4.48 - $10.11 $30,571 - $68,990	-6,824 Reduced 88.17%	916 $8,000
Q3 2023 Nov 01, 2023	SELL	$4.48 - $6.19 $47,922 - $66,214	-10,697 Reduced 58.02%	7,740 $36,000
Q2 2023 Aug 04, 2023	SELL	$4.62 - $7.54 $2,407 - $3,928	-521 Reduced 2.75%	18,437 $98,000
Q1 2023 Apr 27, 2023	BUY	$4.82 - $7.24 $3,224 - $4,843	669 Added 3.66%	18,958 $135,000
Q4 2022 Feb 02, 2023	SELL	$3.34 - $6.98 $3,787 - $7,915	-1,134 Reduced 5.84%	18,289 $122,000
Q3 2022 Nov 04, 2022	SELL	$3.01 - $5.22 $9,379 - $16,265	-3,116 Reduced 13.82%	19,423 $67,000
Q2 2022 Aug 03, 2022	BUY	$2.25 - $9.99 $47,648 - $211,558	21,177 Added 1554.85%	22,539 $66,000
Q1 2022 May 02, 2022	SELL	$8.12 - $16.9 $70,400 - $146,523	-8,670 Reduced 86.42%	1,362 $11,000
Q3 2021 Oct 28, 2021	SELL	$19.74 - $28.7 $33,044 - $48,043	-1,674 Reduced 14.3%	10,032 $282,000
Q2 2021 Aug 12, 2021	SELL	$20.49 - $35.63 $46,676 - $81,165	-2,278 Reduced 16.29%	11,706 $314,000
Q1 2021 Apr 26, 2021	BUY	$18.99 - $33.2 $243,698 - $426,055	12,833 Added 1114.94%	13,984 $445,000
Q4 2020 Feb 02, 2021	BUY	$19.41 - $26.0 $2,270 - $3,042	117 Added 11.32%	1,151 $26,000
Q3 2020 Oct 14, 2020	SELL	$24.69 - $31.6 $22,122 - $28,313	-896 Reduced 46.42%	1,034 $26,000
Q2 2020 Jul 13, 2020	SELL	$5.2 - $29.12 $150 - $844	-29 Reduced 1.48%	1,930 $53,000
Q1 2020 Apr 29, 2020	BUY	$4.28 - $12.11 $8,384 - $23,723	1,959 New	1,959 $11,000
Q4 2019 Feb 05, 2020	SELL	$7.95 - $12.27 $31,028 - $47,889	-3,903 Closed	0 $0
Q3 2019 Oct 15, 2019	SELL	$12.44 - $17.48 $41,562 - $58,400	-3,341 Reduced 46.12%	3,903 $49,000
Q2 2019 Jul 26, 2019	SELL	$14.51 - $19.71 $63,031 - $85,620	-4,344 Reduced 37.49%	7,244 $122,000
Q1 2019 Apr 18, 2019	BUY	$11.11 - $25.6 $127,765 - $294,400	11,500 Added 13068.18%	11,588 $0
Q4 2018 Jan 16, 2019	BUY	$11.75 - $21.42 $176 - $321	15 Added 20.55%	88 $1,000
Q3 2018 Oct 23, 2018	BUY	$19.26 - $23.46 $1,405 - $1,712	73 New	73 $1,000
Q1 2018 Apr 26, 2018	SELL	$18.89 - $32.46 $18,361 - $31,551	-972 Closed	0 $0
Q4 2017 Jan 10, 2018	BUY	$16.19 - $20.3 $15,736 - $19,731	972	972 $18,000

Others Institutions Holding MGNX

# of Institutions

154

Shares Held

60.6M

Call Options Held

218K

Put Options Held

259K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $196M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Macrogenics Inc Transaction History